MTOR and nonpapillary renal cell carcinoma: Here, our results demonstrated that silencing of UQCRH enhances the drug‐induced apoptosis in ccRCC cells (Fig. 6) and that the 5‐aza‐dC treatment sensitizes the antitumor effect of mTOR inhibitor both in vivo and in vitro (Fig. 7).